2024-10-27 00:28:19
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China
Corporate/ 2023-07-23
CanSinoBIO Announces Approval for its MC...

TIANJIN,China,Jan. 9,2022-- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185,HKEX: 06185) announced that the National Medical Pr...

JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building
Corporate/ 2023-07-23
JW Therapeutics Announces Two Appointmen...

SHANGHAI,Jan. 10,2022-- JW Therapeutics (HKEx: 2126),an independent,innovative biotechnology company focusing on developing,manufacturing an...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release